Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations
Authors:
- L. DeprezLDL. Deprez
- S. WeckhuysenSWS. Weckhuysen
- P. HolmgrenPHP. Holmgren
- A. SulsASA. Suls
- T. Van DyckTDT. Van Dyck
- D. GoossensDGD. Goossens
- J. Del-FaveroJDJ. Del-Favero
- A. JansenAJA. Jansen
- K. VerhaertKVK. Verhaert
- L. LagaeLLL. Lagae
- A. JordanovaAJA. Jordanova
- R. Van CosterRCR. Van Coster
- 28 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 75 (13) , 1159-1165
Abstract
Objectives: Heterozygous mutations in STXBP1, encoding the syntaxin binding protein 1, have recently been identified in Ohtahara syndrome, an epileptic encephalopathy with very early onset. In order to explore the phenotypic spectrum associated with STXBP1 mutations, we analyzed a cohort of patients with unexplained early-onset epileptic encephalopathies. Methods: We collected and clinically characterized 106 patients with early-onset epileptic encephalopathies. Mutation analysis of the STXBP1 gene was done using sequence analysis of the exon and intron–exon boundaries and multiplex amplification quantification to detect copy number variations. Results: We identified 4 truncating mutations and 2 microdeletions partially affecting STXBP1 in 6 of the 106 patients. All mutations are predicted to abolish STXBP1 function and 5 mutations were proven to occur de novo. None of the mutation-carrying patients had Ohtahara syndrome. One patient was diagnosed with West syndrome at disease onset, while the initial phenotype of 5 further patients did not fit into a specific recognized epilepsy syndrome. Three of these patients later evolved to West syndrome. All patients had severe to profound mental retardation, and ataxia or dyskinetic movements were present in 5 patients. Conclusion: This study shows that mutations in STXBP1 are not limited to patients with Ohtahara syndrome, but are also present in 10% (5/49) of patients with an early-onset epileptic encephalopathy that does not fit into either Ohtahara or West syndrome and rarely in typical West syndrome. STXBP1 mutational analysis should be considered in the diagnostic evaluation of this challenging group of patients.Keywords
This publication has 11 references indexed in Scilit:
- De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsyAnnals of Neurology, 2009
- Genetics of epilepsy syndromes starting in the first year of lifeNeurology, 2009
- De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathyNature Genetics, 2008
- Munc18-1 expression levels control synapse recovery by regulating readily releasable pool sizeProceedings of the National Academy of Sciences, 2006
- Co-purification and localization of Munc18-1 (p67) and Cdk5 with neuronal cytoskeletal proteinsNeurochemistry International, 2004
- Epileptic Encephalopathies: A Brief OverviewJournal Of Clinical Neurophysiology, 2003
- Epileptic Encephalopathies in Early Infancy With Suppression-BurstJournal Of Clinical Neurophysiology, 2003
- Nomenclature for the description of human sequence variationsHuman Genetics, 2001
- A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and TerminologyEpilepsia, 2001
- Synaptic Assembly of the Brain in the Absence of Neurotransmitter SecretionScience, 2000